Patent · US Active

Injectable hydrogel system to modulate host response at bone implant interface

US9682035B2 · kind B2 · utility

0Cited by

5References

8Claims

0Family size

Assignee

The Board of Trustees of the Leland Stanford Junior University · US

Inventors

Michael Gerard Keeney · Tonawanda, US
Fan Yang · Stanford, US
Stuart B. Goodman · Los Altos, US

Key dates

Filing date	Feb 15, 2013
Grant date	Jun 20, 2017
Priority date	—
Expiry date	Feb 28, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2430/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A bone implant primer is provided. A biodegradable hydrogel component is provided. A plurality of biomolecule release depots are dispersed within the biodegradable hydrogel component wherein the plurality of biomolecule release depots comprise biomolecules for aiding implant osseointegration or biomolecules for mitigation of foreign body response. Different biomolecules may be released by the microspheres at different times.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.